Cefdinir and Daptomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Daptomycin (daptomycin). Common drug interactions include small intestinal obstruction among females and hallucination among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Daptomycin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.



On Jul, 12, 2026

12 people who take Cefdinir and Daptomycin together, and have interactions are studied.

Cefdinir and Daptomycin drug interactions.

What are the common drug interactions of Cefdinir and Daptomycin, by gender? *:

female:

  1. Small intestinal obstruction (blockage in small intestine)
  2. Chronic kidney disease
  3. Death
  4. Dyspepsia (indigestion)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Renal failure (kidney dysfunction)
  7. Renal injury (kidney injury)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

male:

  1. Hallucination (an experience involving the perception of something not present)
  2. Confusional state
  3. Pain in extremity
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Skin ulcer
  7. Agitation (state of anxiety or nervous excitement)
  8. Cystitis (inflammation of the wall of the bladder)
  9. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  10. Death

What are the common drug interactions of Cefdinir and Daptomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

60+:

  1. Hallucination (an experience involving the perception of something not present)
  2. Confusional state
  3. Pain in extremity
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  6. Skin ulcer
  7. Agitation (state of anxiety or nervous excitement)
  8. Death
  9. Small intestinal obstruction (blockage in small intestine)
  10. Chronic kidney disease

What are the existing conditions these people have? *

  1. Urinary Tract Infection: 4 people, 33.33%
  2. Parkinson's Disease: 4 people, 33.33%
  3. High Blood Pressure: 3 people, 25.00%
  4. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 25.00%
  5. Pain: 3 people, 25.00%
  6. Infection: 3 people, 25.00%
  7. Depression: 3 people, 25.00%
  8. Leukocytosis (increased white blood cells): 3 people, 25.00%
  9. Stress And Anxiety: 3 people, 25.00%
  10. Nausea (feeling of having an urge to vomit): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Daptomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daptomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and daptomycin (the active ingredients of Cefdinir and Daptomycin, respectively), and Cefdinir and Daptomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: